Unknown

Dataset Information

0

Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-?-stimulated gene-6 in inflammatory bowel disease models.


ABSTRACT: Therapeutic applications of tissue-derived mesenchymal stem cells (MSCs) are hindered by their limited expansion ability and variation across donors. Human induced pluripotent stem cell (iPSC)-derived MSCs show greater expandability and therefore offer potential for use in tissue repair therapies. Here we explored the regenerative effects of iPSC-MSCs and the mechanisms by which iPSC-MSCs promote mucosal healing via tumor necrosis factor-?-stimulated gene 6 (TSG-6) in mouse models of inflammatory bowel disease (IBD). Human iPSCs were induced to differentiate into MSCs following a clinically compliant protocol. The iPSC-MSC treatment promoted mucosal healing in colitic mice, accompanied by increased epithelial cell proliferation, CD44-positive cells, and Lgr5-positive cells. TSG-6 knockdown in iPSC-MSCs or blocking of hyaluronan-CD44 interactions by PEP-1 abrogated the therapeutic effects of iPSC-MSCs, whereas use of recombinant TSG-6 showed therapeutic effects similar to those of iPSC-MSCs. A mouse or patient-derived organoid culture system was developed. Organoids co-cultured with iPSC-MSCs showed increased epithelial cell proliferation, CD44-positive cells, and Lgr5-positive cells, which was abolished by TSG-6 knockdown. TSG-6-induced promoting effects in organoids were dependent on Akt activation and abrogated by the anti-CD44 antibody or MK2206. In conclusion, iPSC-MSCs promoted epithelial cell proliferation to accelerate mucosal healing in a murine colitis model via TSG-6 through hyaluronan-CD44 interactions in an Akt-dependent manner, demonstrating a patient-specific "off-the-shelf" format for IBD treatment.

SUBMITTER: Yang H 

PROVIDER: S-EPMC6763610 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models.

Yang Hongsheng H   Feng Rui R   Fu Qingling Q   Xu Shu S   Hao Xiuxue X   Qiu Yun Y   Feng Ting T   Zeng Zhirong Z   Chen Minhu M   Zhang Shenghong S  

Cell death & disease 20190926 10


Therapeutic applications of tissue-derived mesenchymal stem cells (MSCs) are hindered by their limited expansion ability and variation across donors. Human induced pluripotent stem cell (iPSC)-derived MSCs show greater expandability and therefore offer potential for use in tissue repair therapies. Here we explored the regenerative effects of iPSC-MSCs and the mechanisms by which iPSC-MSCs promote mucosal healing via tumor necrosis factor-α-stimulated gene 6 (TSG-6) in mouse models of inflammator  ...[more]

Similar Datasets

| S-EPMC5531092 | biostudies-literature
| S-EPMC9322434 | biostudies-literature
| S-EPMC6325075 | biostudies-other
| S-EPMC5189643 | biostudies-literature
| S-EPMC4907544 | biostudies-literature
| S-EPMC4055091 | biostudies-literature
| S-EPMC4059645 | biostudies-literature
| S-EPMC5980202 | biostudies-literature
| S-EPMC9349189 | biostudies-literature
| S-EPMC7038387 | biostudies-literature